HYDANTOIN DERIVATIVE

A compound of formula (I-a):wherein the symbols are defined in the specification, and which has a strong DDR1 inhibitory activity, and can be a therapeutic agent for DDR1-related diseases, for example, a cancer, a kidney disease, a cardiovascular disease, a central nervous system disease, or fibrosi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LV, Ranran, NISHIZAWA, Rena, NISHIOKA, Yota, GAO, Xuechao, GOLDSMITH, Michael, BANDODKAR, Balachandra, WAN, Zhilong, KURONO, Masakuni, DOYLE, Kevin
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator LV, Ranran
NISHIZAWA, Rena
NISHIOKA, Yota
GAO, Xuechao
GOLDSMITH, Michael
BANDODKAR, Balachandra
WAN, Zhilong
KURONO, Masakuni
DOYLE, Kevin
description A compound of formula (I-a):wherein the symbols are defined in the specification, and which has a strong DDR1 inhibitory activity, and can be a therapeutic agent for DDR1-related diseases, for example, a cancer, a kidney disease, a cardiovascular disease, a central nervous system disease, or fibrosis.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2022306640A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2022306640A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2022306640A13</originalsourceid><addsrcrecordid>eNrjZBDxiHRx9Avx9_RTcHEN8gxzDPEMc-VhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGhwUYGRkbGBmZmJgaOhsbEqQIAAZcfog</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>HYDANTOIN DERIVATIVE</title><source>esp@cenet</source><creator>LV, Ranran ; NISHIZAWA, Rena ; NISHIOKA, Yota ; GAO, Xuechao ; GOLDSMITH, Michael ; BANDODKAR, Balachandra ; WAN, Zhilong ; KURONO, Masakuni ; DOYLE, Kevin</creator><creatorcontrib>LV, Ranran ; NISHIZAWA, Rena ; NISHIOKA, Yota ; GAO, Xuechao ; GOLDSMITH, Michael ; BANDODKAR, Balachandra ; WAN, Zhilong ; KURONO, Masakuni ; DOYLE, Kevin</creatorcontrib><description>A compound of formula (I-a):wherein the symbols are defined in the specification, and which has a strong DDR1 inhibitory activity, and can be a therapeutic agent for DDR1-related diseases, for example, a cancer, a kidney disease, a cardiovascular disease, a central nervous system disease, or fibrosis.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220929&amp;DB=EPODOC&amp;CC=US&amp;NR=2022306640A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220929&amp;DB=EPODOC&amp;CC=US&amp;NR=2022306640A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LV, Ranran</creatorcontrib><creatorcontrib>NISHIZAWA, Rena</creatorcontrib><creatorcontrib>NISHIOKA, Yota</creatorcontrib><creatorcontrib>GAO, Xuechao</creatorcontrib><creatorcontrib>GOLDSMITH, Michael</creatorcontrib><creatorcontrib>BANDODKAR, Balachandra</creatorcontrib><creatorcontrib>WAN, Zhilong</creatorcontrib><creatorcontrib>KURONO, Masakuni</creatorcontrib><creatorcontrib>DOYLE, Kevin</creatorcontrib><title>HYDANTOIN DERIVATIVE</title><description>A compound of formula (I-a):wherein the symbols are defined in the specification, and which has a strong DDR1 inhibitory activity, and can be a therapeutic agent for DDR1-related diseases, for example, a cancer, a kidney disease, a cardiovascular disease, a central nervous system disease, or fibrosis.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBDxiHRx9Avx9_RTcHEN8gxzDPEMc-VhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGhwUYGRkbGBmZmJgaOhsbEqQIAAZcfog</recordid><startdate>20220929</startdate><enddate>20220929</enddate><creator>LV, Ranran</creator><creator>NISHIZAWA, Rena</creator><creator>NISHIOKA, Yota</creator><creator>GAO, Xuechao</creator><creator>GOLDSMITH, Michael</creator><creator>BANDODKAR, Balachandra</creator><creator>WAN, Zhilong</creator><creator>KURONO, Masakuni</creator><creator>DOYLE, Kevin</creator><scope>EVB</scope></search><sort><creationdate>20220929</creationdate><title>HYDANTOIN DERIVATIVE</title><author>LV, Ranran ; NISHIZAWA, Rena ; NISHIOKA, Yota ; GAO, Xuechao ; GOLDSMITH, Michael ; BANDODKAR, Balachandra ; WAN, Zhilong ; KURONO, Masakuni ; DOYLE, Kevin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2022306640A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>LV, Ranran</creatorcontrib><creatorcontrib>NISHIZAWA, Rena</creatorcontrib><creatorcontrib>NISHIOKA, Yota</creatorcontrib><creatorcontrib>GAO, Xuechao</creatorcontrib><creatorcontrib>GOLDSMITH, Michael</creatorcontrib><creatorcontrib>BANDODKAR, Balachandra</creatorcontrib><creatorcontrib>WAN, Zhilong</creatorcontrib><creatorcontrib>KURONO, Masakuni</creatorcontrib><creatorcontrib>DOYLE, Kevin</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LV, Ranran</au><au>NISHIZAWA, Rena</au><au>NISHIOKA, Yota</au><au>GAO, Xuechao</au><au>GOLDSMITH, Michael</au><au>BANDODKAR, Balachandra</au><au>WAN, Zhilong</au><au>KURONO, Masakuni</au><au>DOYLE, Kevin</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>HYDANTOIN DERIVATIVE</title><date>2022-09-29</date><risdate>2022</risdate><abstract>A compound of formula (I-a):wherein the symbols are defined in the specification, and which has a strong DDR1 inhibitory activity, and can be a therapeutic agent for DDR1-related diseases, for example, a cancer, a kidney disease, a cardiovascular disease, a central nervous system disease, or fibrosis.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2022306640A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
title HYDANTOIN DERIVATIVE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T06%3A52%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LV,%20Ranran&rft.date=2022-09-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2022306640A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true